Ablation of TAK1 Upregulates Reactive Oxygen Species and Selectively Kills Tumor Cells
- 31 October 2010
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 70 (21) , 8417-8425
Abstract
TAK1 kinase activates multiple transcription factors and regulates the level of reactive oxygen species (ROS). We have previously reported that ablation of TAK1 in keratinocytes causes hypersensitivity to ROS-induced cell apoptosis. It is known that some tumor cells produce ROS at higher levels compared with normal cells. We used inducible epidermal-specific TAK1 knockout mice and examined whether ablation of TAK1 in preexisting skin tumors could cause an increase in ROS and result in tumor cell death. Deletion of tak1 gene in skin tumors caused the accumulation of ROS and increased apoptosis, and skin tumors totally regressed within 5 to 10 days. Normal skin did not exhibit any significant abnormality on tak1 gene deletion. Thus, TAK1 kinase could be a new and effective molecular target for ROS-based tumor killing. Cancer Res; 70(21); 8417–25. ©2010 AACR.Keywords
This publication has 23 references indexed in Scilit:
- Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?Nature Reviews Drug Discovery, 2009
- Association of reactive oxygen species levels and radioresistance in cancer stem cellsNature, 2009
- Akt Determines Replicative Senescence and Oxidative or Oncogenic Premature Senescence and Sensitizes Cells to Oxidative ApoptosisCancer Cell, 2008
- TAK1 Regulates Reactive Oxygen Species and Cell Death in Keratinocytes, Which Is Essential for Skin IntegrityJournal of Biological Chemistry, 2008
- Genetic Ablation of CCAAT/Enhancer Binding Protein α in Epidermis Reveals Its Role in Suppression of Epithelial TumorigenesisCancer Research, 2007
- Essential role of TAK1 in thymocyte development and activationProceedings of the National Academy of Sciences, 2006
- TAK1 Is a Master Regulator of Epidermal Homeostasis Involving Skin Inflammation and ApoptosisJournal of Biological Chemistry, 2006
- TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivoGenes & Development, 2005
- NF-κB at the crossroads of life and deathNature Immunology, 2002
- Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harvey-ras oncogeneNature, 1983